Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
27 studies found for:    Cystic Fibrosis | Open Studies | NIH, U.S. Fed
Show Display Options
Download search resultsDownload the search results for:
Cystic Fibrosis | Open Studies | NIH, U.S. Fed (27 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance
Condition: Cystic Fibrosis
Intervention:
2 Recruiting Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Condition: Cystic Fibrosis
Intervention:
3 Recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
4 Recruiting Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
Condition: Cystic Fibrosis
Intervention:
5 Recruiting The Role of Bacteria and Genetic Variations in Cystic Fibrosis
Condition: Lung Diseases
Intervention:
6 Unknown  Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
7 Recruiting Comparing Chest Images From MRI to CT in Patients With Cystic Fibrosis (CF)
Condition: Cystic Fibrosis
Intervention:
8 Recruiting Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens
Condition: Cystic Fibrosis
Intervention:
9 Recruiting Natural History of Bronchiectasis
Conditions: Bronchiectasis;   Cystic Fibrosis;   Autoimmune Disease;   Common Variable Immunodeficiency
Intervention:
10 Unknown  Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging
Condition: Cystic Fibrosis
Interventions: Procedure: FDG-PET;   Procedure: spirometry;   Procedure: bronchoscopy with BAL
11 Recruiting BioEnergetics and Metabolomics in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
12 Recruiting OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: azithromycin;   Drug: placebo;   Drug: Tobramycin solution for inhalation
13 Recruiting Genetic Modifiers of Cystic Fibrosis Related Diabetes
Condition: Cystic Fibrosis Related Diabetes
Intervention:
14 Recruiting Using MRI to Observe Lung Changes in Infants With CF Compared to Infants Without CF
Condition: Cystic Fibrosis
Intervention:
15 Recruiting Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI
Condition: Cystic Fibrosis
Intervention: Drug: Hyperpolarized Xenon
16 Recruiting Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa
Conditions: Pseudomonas Infection;   Cystic Fibrosis
Intervention:
17 Recruiting Study of Mycobacterial Infections
Conditions: Atypical Mycobacterium Infections;   Cystic Fibrosis;   Job's Syndrome
Intervention:
18 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
19 Recruiting Role of Genetic Factors in the Development of Lung Disease
Conditions: Cystic Fibrosis;   Sarcoidosis;   Tuberous Sclerosis;   Asthma
Intervention:
20 Recruiting Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With CF
Condition: Cystic Fibrosis
Interventions: Drug: azithromycin;   Drug: placebo (for azithromycin);   Drug: inhaled tobramycin

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years